TP53 and head and neck squamous cell carcinoma: Our results thus far (Figs. 1–5) strongly suggest that inhibition of AMPK-mediated FOXO3a activation could be an important mechanism contributing to GOF mutant p53-mediated FOXM1 up-regulation in HNSCC cells.